Ranking biomarkers in an agnostic manner using MR-BMA reinforced our confidence in the strength of our findings and provided us with information about the importance of testosterone, HDL cholesterol, IGF-1, and ALP in breast cancer liability. This evidence concerns the gene IGF1 and breast carcinoma.